Inserm Unit 1088, UFR de Médecine et de Pharmacie, Université de Picardie Jules Verne, Amiens, France.
Kidney Int. 2012 Nov;82(9):952-60. doi: 10.1038/ki.2012.270. Epub 2012 Aug 1.
The kidney disease improving global outcomes (KDIGO) clinical practice guideline for anemia in chronic kidney disease (CKD) is designed to assist health-care providers in treating CKD patients with anemia. A guideline is not intended to define a standard of care, and should not be construed as one, nor should it be interpreted as prescribing an exclusive course of management. It is intended to provide information and to allow the practitioner to make an informed decision, based on evidence and expert judgment. Every health-care professional making use of these recommendations is responsible for evaluating the appropriateness of applying them in any particular clinical situation. Owing to the general nature of a guideline, it is sometimes difficult to translate it to an individual patient's condition. As the primary goal is to improve patient care, we have decided to focus on practical clinical aspects of the KDIGO anemia guideline.
肾脏疾病改善全球结果组织（KDIGO）慢性肾脏病（CKD）贫血临床实践指南旨在帮助医疗保健提供者治疗 CKD 贫血患者。指南的目的不是定义护理标准，也不应被视为标准，也不应被解释为规定了排他性的管理方案。它旨在提供信息，并允许从业者根据证据和专家判断做出明智的决策。每个使用这些建议的医疗保健专业人员都有责任评估在任何特定临床情况下应用它们的适当性。由于指南的普遍性，有时将其转化为个体患者的情况会比较困难。由于主要目标是改善患者的护理，我们决定专注于 KDIGO 贫血指南的实际临床方面。
